Skip to main content
Caplight Logo









Derm-Biome Pharmaceuticals

Derm-Biome Pharmaceuticals

Private
VancouverHealthcare & Life Scienceshttps://www.crossroadsracingseries.com/

Last Round

Grant

May 8, 2024

Total Funding Raised

$328,000

Company Overview

Derm-Biome Pharmaceuticals is a biotechnology company that develops novel topical therapies for inflammatory skin diseases, precancerous skin conditions, and aging skin.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverytopical therapiespreclinical researchdermatologybiotech startupinflammatory skin diseaseoncologysmall-molecule drugsactinic keratosis treatmentatopic dermatitisdrug pipelinebiopharmapreclinical pharmacologytherapeutic development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Derm-Biome Pharmaceuticals Comparables

Compare Derm-Biome Pharmaceuticals with similar companies based on industry and business-model similarity.

Derm-Biome Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DFB Pharmaceuticals
79%
Vertes Therapeutics
79%
Vidac Pharma Holding PLC
78%

Derm-Biome Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 8, 2024
SeedApr 17, 2024
Pre SeedJul 2, 2020

Derm-Biome Pharmaceuticals Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 8, 2024

    $328K grant received from Canadian government agencies.

Derm-Biome Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Derm-Biome Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Derm-Biome Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Year FoundedN/A
Last FundingMay 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?